Both in Pharmaceuticals
Acadia Pharmaceuticals vs Enliven Therapeutics
Over the past year ACAD returned −5.6% and ELVN returned +123.9%; their daily moves had a correlation of 0.18.
ACAD −5.6% ELVN +123.9%Growth of $1, one year, split-adjusted
| Metric | ACAD | ELVN |
|---|---|---|
| Price | $20.15 | $45.84 |
| Market cap | $3.47B | $3.36B |
| Today | −0.35% | −1.44% |
| 1 month | −30.3% | −20.8% |
| 6 months | −9.5% | +16.9% |
| Year to date | −24.6% | +197.7% |
| 1 year | −5.5% | +125.8% |
| Revenue growth (YoY) | +16.4% | — |
| Gross margin | 90.8% | — |
| Net margin | 10.2% | — |
| P/E (TTM) | 9.1× | — |
| Price / sales | 3.0× | — |
| Net cash | $956.5M | $895.2M |
| Dividend yield | — | — |
| Volatility (60d) | 45.5% | 39.5% |
| Short % of float | 5.7% | 14.2% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).